Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease

ClinicalTrials.gov ID: NCT01074125

Public ClinicalTrials.gov record NCT01074125. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 21, 2026, 9:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A 4-Week Dose-Ranging and Efficacy Trial of KRX-0502 (Ferric Citrate) in Patients With End-Stage Renal Disease (ESRD) Following a Two-Week Washout Period

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a research study for people with high blood phosphorus levels who are on dialysis. This medical condition can cause weakening of the bones and damage other organs. This can lead to many health problems, and sometimes death. Phosphorus is in much of the food we eat, and is helpful to us in small amounts. Patients with kidney failure have trouble getting rid of the phosphorus eaten in food. Dialysis can help remove some of the phosphorus, but often patients must take a phosphate binder like PhosLo®, Renagel®, or Renvela® to bring the blood phosphorus levels back to normal. The purpose of this study is to see if KRX-0502 (ferric citrate) is safe and effective as a phosphate binder.

Study identification

NCT ID
NCT01074125
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Keryx Biopharmaceuticals
Industry
Enrollment
154 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2010 (Type not available)
Primary completion
Nov 2010 (Actual)
Completion
Nov 2010 (Actual)
Last update posted
Dec 4, 2014

2010

United States locations

U.S. sites
15
U.S. states
10
U.S. cities
13
Facility City State ZIP Site status
Western Nephrology Westminster Colorado 80031 —
Pines Clinical Research, Inc. Pembroke Pines Florida 33028 —
Kidney Care Associates, LLC Augusta Georgia 30901 —
Circle Medical Management Chicago Illinois 60607 —
Western New England Renal & Transplant Associates Springfield Massachusetts 01107 —
Brookdale Physician's Dialysis Associates Brooklyn New York 11212 —
DCI Cincinnati Ohio 45206 —
Cleveland Clinical Foundation Fresenius East (Fairhill) Cleveland Ohio 44104 —
The Ohio State University Cramblett Medical Clinic Columbus Ohio 43210 —
Southeast Renal Research Institute Chattanooga Tennessee 37404 —
Nephrology Associates, PC Nashville Tennessee 37205 —
Meharry Medical College Clinical Research Center Nashville Tennessee 37208 —
Vanderbilt University Medical Center Clinical Trials Center Nashville Tennessee 37232-1371 —
Kidney Associates Houston Texas 77030 —
Centre Point Dialysis West Allis Wisconsin 53214 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01074125, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 4, 2014 · Synced Oct 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01074125 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →